Sydney Jennings

US News and World Report released its annual “Best Diets” rankings for 2023. Out of nearly 40 of the most popular diets ranked by health experts, these 10 came out on top.

Findings suggest that school-based gardening, nutrition, and cooking interventions may improve metabolic parameters in high-risk children.

Get a quick look at 15 of the many FDA-approved drugs in 2022 for conditions commonly seen in primary care.

Adolescents with more positive psychological assets were more likely to have good cardiometabolic health 2 decades later, and associations were stronger for Black youth.

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Mayo Clinic's Andres Acosta, MD, PhD.

Your daily dose of clinical news you may have missed.

Your daily dose of clinical news you may have missed.

Findings elaborate on the pathophysiological differences in autoimmunity and atrial fibrillation risk between men and women.

Your daily dose of clinical news you may have missed.

Direct-acting antiviral treatment was independently associated with a lower risk of mortality and liver and nonliver outcomes in a large study of adults with chronic hepatitis C.

Findings highlight the need for extended efforts directed to prevent childhood obesity, especially targeting lower socioeconomic areas, say study authors.

Your daily dose of clinical news you may have missed.

Findings showed that greater concordance to the Mediterranean diet was linked to a 21% lower risk of developing any adverse pregnancy outcomes.

Commotio cordis is among the theories circulating around Buffalo Bills safety Damar Hamlin's on-field cardiac arrest.

A new study points to the Pfizer shot's initially limited protection against the COVID-19 Omicron variant in those aged 5-11 years and also the the value of vaccine boosters.

Lenacapavir is the first of a new class of antiretrovirals, and it is indicated for persons with multidrug resistance, intolerance, or safety considerations.

Your daily dose of clinical news you may have missed.

Your daily dose of clinical news you may have missed.

Data from a phase 1 study of nondependent recreational opioid users suggests cebranopadol has a lower potential for abuse compared to C-II and C-IV opioids

Your daily dose of clinical news you may have missed.

The end of another quarter means a new list of FDA-approved drugs for conditions treated in primary care. Are you up-to-date? Click through to find out.

Your daily dose of clinical news you may have missed.

Your daily dose of clinical news you may have missed.

The FDA has granted priority review to a biologics license application for Pfizer’s respiratory syncytial virus vaccine candidate, RSVpreF, for adults aged ≥60 years.

Drug overdose deaths increased approximately 81% among pregnant and postpartum women in the US from 2017 to 2020, according to new research.

Your daily dose of clinical news you may have missed.

Your daily dose of clinical news you may have missed.

Pfizer and BioNTech submitted an application to the FDA for emergency use authorization of their omicron BA.4/BA.5-adapted bivalent COVID-19 vaccines in children aged 6 months to 4 years.

Your daily dose of clinical news you may have missed.